Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.

It was previously shown that cyclosporine A (CsA) increases transepithelial resistance in MDCK cells. Activation of the extracellular signal-regulated kinase 1/2 (ERK1/2) mitogen-activated protein kinase (MAPK) cascade seems to be pivotal to the CsA-induced increase in transepithelial electrical resistance (TER). This study examined the role played by TGF-beta in mediating the CsA-induced activation of ERK1/2 and the resulting increase in TER in MDCK cells. Paracellular permeability across MDCK monolayers after various treatments was assessed by measurement of TER. TGF-beta secretion was measured by Western blot and ELISA. Activation of the ERK1/2 pathway and tight junction protein expression were also assessed by Western blot analysis. CsA increased production and secretion of TGF-beta and expression of the TGF-beta receptor II. Exogenous addition of TGF-beta1 activated ERK1/2 and increased TER across MDCK monolayers, both of which were attenuated by the MEK inhibitor U0126. Neutralizing antibodies against TGF-beta1 and the TGF-beta receptor II significantly reduced the CsA-induced increase in TER. Both CsA and TGF-beta1 increased expression of tight junction proteins claudin-1 and zonula occludens 2. Inhibition of the p38 MAPK pathway also attenuated the TGF-beta1-induced increase in TER. The results presented here suggest that the CsA-induced modulation of paracellular permeability may be mediated, at least in part, by an increase in TGF-beta production.

[1]  D. Balkovetz Opening Pandora's box in the tight junction. , 2007, Journal of the American Society of Nephrology : JASN.

[2]  D. McKay,et al.  Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability. , 2005, The American journal of pathology.

[3]  T. McMorrow,et al.  Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. , 2005, The American journal of pathology.

[4]  J. Lipschutz,et al.  Extracellular Signal-regulated Kinases 1/2 Control Claudin-2 Expression in Madin-Darby Canine Kidney Strain I and II Cells* , 2005, Journal of Biological Chemistry.

[5]  H. Moses,et al.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.

[6]  T. Tsuruo,et al.  Transforming Growth Factor-β1 Upregulates the Tight Junction and P-glycoprotein of Brain Microvascular Endothelial Cells , 2004, Cellular and Molecular Neurobiology.

[7]  C. Cheng,et al.  Regulation of blood-testis barrier dynamics: an in vivo study , 2004, Journal of Cell Science.

[8]  R. Harris,et al.  Epidermal Growth Factor Receptor Activation Differentially Regulates Claudin Expression and Enhances Transepithelial Resistance in Madin-Darby Canine Kidney Cells* , 2004, Journal of Biological Chemistry.

[9]  J. Matthews,et al.  Bryostatin-1 enhances barrier function in T84 epithelia through PKC-dependent regulation of tight junction proteins. , 2003, American journal of physiology. Cell physiology.

[10]  C. Cheng,et al.  TGF-betas: their role in testicular function and Sertoli cell tight junction dynamics. , 2003, International journal of andrology.

[11]  C. Cheng,et al.  TGF-beta3 regulates the blood-testis barrier dynamics via the p38 mitogen activated protein (MAP) kinase pathway: an in vivo study. , 2003, Endocrinology.

[12]  M. Ryan,et al.  Modulation of renal epithelial barrier function by mitogen-activated protein kinases (MAPKs): mechanism of cyclosporine A-induced increase in transepithelial resistance. , 2003, Kidney international.

[13]  J. Gauldie,et al.  TGF-beta effects on epithelial ion transport and barrier: reduced Cl- secretion blocked by a p38 MAPK inhibitor. , 2002, American journal of physiology. Cell physiology.

[14]  L. Ericson,et al.  Transforming growth factor-β and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes , 2002, Journal of Cell Science.

[15]  K. Budde,et al.  Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  L. González-Mariscal,et al.  Nuclear localization of the tight junction protein ZO-2 in epithelial cells. , 2002, Experimental cell research.

[17]  W. Lui,et al.  Transforming Growth Factor-β3 Perturbs the Inter-Sertoli Tight Junction Permeability Barrier in Vitro Possibly Mediated via Its Effects on Occludin, Zonula Occludens-1, and Claudin-11. , 2001, Endocrinology.

[18]  S. Tsukita,et al.  Conversion of Zonulae Occludentes from Tight to Leaky Strand Type by Introducing Claudin-2 into Madin-Darby Canine Kidney I Cells , 2001, The Journal of cell biology.

[19]  K. Sharma,et al.  Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. , 2001, Kidney international.

[20]  P. Muriel,et al.  Tight junction proteins ZO-1, ZO-2, and occludin along isolated renal tubules. , 2000, Kidney international.

[21]  T. Inai,et al.  Claudin-1 contributes to the epithelial barrier function in MDCK cells. , 1999, European journal of cell biology.

[22]  C. Fiocchi,et al.  Transforming growth factor‐β1 preserves epithelial barrier function: Identification of receptors, biochemical intermediates, and cytokine antagonists , 1999, Journal of cellular physiology.

[23]  C. Hawkey,et al.  Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response. , 1999, American journal of physiology. Cell physiology.

[24]  K. Stelwagen,et al.  An anti-inflammatory component derived from milk of hyperimmunised cows reduces tight junction permeability in vitro , 1998, Inflammation Research.

[25]  V. Sharma,et al.  In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine. , 1998 .

[26]  D. McKay,et al.  Superantigen activation of immune cells evokes epithelial (T84) transport and barrier abnormalities via IFN-gamma and TNF alpha: inhibition of increased permeability, but not diminished secretory responses by TGF-beta2. , 1997, Journal of immunology.

[27]  M. Suthanthiran,et al.  In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine. , 1997, Transplantation.

[28]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[29]  C. Marano,et al.  Tissue remodeling during tumor necrosis factor-induced apoptosis in LLC-PK1 renal epithelial cells. , 1996, The American journal of physiology.

[30]  G. Firestone,et al.  Antagonistic Regulation of Tight Junction Dynamics by Glucocorticoids and Transforming Growth Factor- in Mouse Mammary Epithelial Cells (*) , 1996, The Journal of Biological Chemistry.

[31]  S. Lewis,et al.  Cell division does not increase transepithelial permeability of LLC-PK1 cell sheets. , 1995, Experimental cell research.

[32]  L. M. Russo,et al.  Long‐term effects of tumor necrosis factor on LLC‐PK1 transepithelial resistance , 1993, Journal of cellular physiology.

[33]  D. Podolsky,et al.  Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. , 1993, Gastroenterology.

[34]  M. Welsh,et al.  Cadmium in vivo causes disruption of tight junction-associated microfilaments in rat Sertoli cells. , 1993, Biology of reproduction.

[35]  A. Thomson,et al.  Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies. , 1985, Transplantation proceedings.

[36]  S H MADIN,et al.  Established Kidney Cell Lines of Normal Adult Bovine and Ovine Origin.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  T. Tsuruo,et al.  Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells. , 2004, Cellular and molecular neurobiology.

[38]  C. Cheng,et al.  Transforming Growth Factor-b 3 Perturbs the Inter-Sertoli Tight Junction Permeability Barrier in Vitro Possibly Mediated via Its Effects on Occludin , Zonula Occludens-1 , and Claudin-11 * , 2001 .

[39]  W. Bennett,et al.  Nephrotoxocity of immunosuppressive drugs , 1994 .

[40]  B. Ryffel,et al.  Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine A. , 1987, Ultrastructural pathology.

[41]  B. Ryffel,et al.  Morphology of cyclosporine nephrotoxicity in the rat. , 1986, Clinical nephrology.